Literature DB >> 30298685

In-hospital opioid consumption, but not pain intensity scores, predicts 6-month levels of pain catastrophizing following hepatic resection: A trajectory analysis.

M Gabrielle Pagé1,2, Paul J Karanicolas3,4, Sean Cleary5,6, Alice C Wei5, Paul McHardy7, Salima S J Ladak8,9, Nour Ayach10, Jason Sawyer7, Stuart A McCluskey10, Coimbatore Srinivas10, Joel Katz8,10,11, Natalie Coburn3,4, Julie Hallet3, Calvin Law3,4, Paul Greig3, Hance Clarke8,10.   

Abstract

BACKGROUND: The study aims were to model acute pain intensity and opioid consumption trajectories up to 72 hr after open hepatic resection, identify predictors of trajectory membership and examine the association between trajectory memberships and 6-month pain and psychological outcomes. This is a long-term analysis of a published randomized controlled trial on the impact of medial open transversus abdominis plane catheters on post-operative outcomes.
METHODS: A total of 152 patients (89 males; mean age 63.0 [range: 54-72]) completed questionnaires on pain and related characteristics pre-operatively and 6 months post-operatively. Total opioid use was recorded several times over a 72-hr period while self-reported pain intensity scores were collected multiple times until hospital discharge. Analyses were carried out using growth mixture modelling, logistic regression and general linear models.
RESULTS: Both pain intensity and opioid consumption showed that a four-trajectory model best fits the data. Patients in the lowest opioid consumption trajectory were more likely to be classified in the constant mild pain intensity trajectory. Age and baseline levels of anxiety significantly predicted opioid trajectory membership while baseline depressive symptoms significantly predicted pain intensity trajectory membership. Patients in the two highest opioid consumption trajectories reported significantly higher levels of pain catastrophizing at 6 months compared to patients in the other 3 trajectories (all p < 0.05).
CONCLUSION: High consumption of opioids after surgery is associated with higher levels of pain catastrophizing 6 months later. Identification of patients within these trajectories may lead to the development of early interventions targeted to high risk individuals. SIGNIFICANCE: Differences in initial levels of opioid consumption and rates of change in opioid consumption shortly after surgery can help predict long-term psychological responses to pain. Identifying key characteristics associated with initial opioid consumption can lead to the development of cost-effective early interventions targeted to high risk individuals.
© 2018 European Pain Federation - EFIC®.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30298685     DOI: 10.1002/ejp.1324

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  4 in total

1.  Acute postoperative opioid consumption trajectories and long-term outcomes in pediatric patients after spine surgery.

Authors:  Mandy Mj Li; Don Daniel Ocay; Alisson R Teles; Pablo M Ingelmo; Jean A Ouellet; M Gabrielle Pagé; Catherine E Ferland
Journal:  J Pain Res       Date:  2019-05-23       Impact factor: 3.133

2.  Influential factors of postoperative pain trajectories in patients receiving intravenous patient-controlled analgesia: a single-centre cohort study in Taiwan.

Authors:  Ying-Hsuan Tai; Hsiang-Ling Wu; Shih-Pin Lin; Mei-Yung Tsou; Kuang-Yi Chang
Journal:  BMJ Open       Date:  2019-11-07       Impact factor: 2.692

3.  An Interactive Pain Application (MServ) Improves Postoperative Pain Management.

Authors:  Richard Gordon-Williams; Andreia Trigo; Paul Bassett; Amanda Williams; Stephen Cone; Martin Lees; Brigitta Brandner
Journal:  Pain Res Manag       Date:  2021-04-02       Impact factor: 3.037

4.  Influential Factors and Personalized Prediction Model of Acute Pain Trajectories after Surgery for Renal Cell Carcinoma.

Authors:  Hsin-Jung Tsai; Wen-Kuei Chang; Fang-Yu Yen; Shih-Pin Lin; Tzu-Ping Lin; Kuang-Yi Chang
Journal:  J Pers Med       Date:  2022-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.